Vyxeos™ (daunorubicin/cytarabine) – New orphan drug approval
August 3, 2017 – The FDA announced the approval of Jazz Pharmaceuticals’ Vyxeos (daunorubicin/ cytarabine) for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).
Top